RAS-antagonist and beta-blocker up-to maximal dosages Clinical Trials

1 actively recruiting trial

Also known as: Bisoprolol 10mg/d, Candesartan 32mg/d, Captopril 150mg/d, Carvedilol 50mg/d (100mg/d if weight is > 85kg), Cilazapril 5mg/d, Enalapril 40mg/d, Eprosartan 800mg/d, Fosinopril 40mg/d, Irbesartan 300mg/d, Lisinopril 40mg/d, Losartan 150mg/d, Metoprololsuccinat 200mg/d, Nebivolol 10mg/d, Perindopril 8mg/d, Quinapril 40mg/d, Ramipril 10mg/d, Spirapril 24mg/d, Trandolapril 4mg/d, Valsartan 320mg/d, Zofenopril 60mg/d

Filter by location:

Other1 trial

NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.